represented a significant improvement in terms of workup
procedures by avoiding chromatographic purification and
consequent hydrolysis of the imino moiety and allowing high
yields of the final product to be isolated. The classic X )
Y-ZH sequence in the general BK rearrangement scheme
(see above) points out the key role of the potentially acidic
Z-H proton.
N(2) atom of the oxadiazole ring. Rearomatization of
intermediates 10 and final protonation produces target
imidazoles 5 (Scheme 3). In conclusion, we report the first
exampleofaCNCsidechaininvolvedintheBoulton-Katritzky
reaction, which enhances the breadth of this well-studied and
widely applied reaction. Starting substrates were obtained
Scheme 3
.
Proposed Mechanism for BK Rearrangement of
Table 2. Rearrangement of Imines 4 into Imidazoles 5
Compounds 4
entry
product
5 yield (%)a
1
2
3
4
5
6
7
8
9
a: Ar ) Ph
89
86
63
80
80
76
71
71
52
b: Ar ) 4-MePh
c: Ar ) 4-MeOPh
d: Ar ) 4-NO2Ph
e: Ar ) 4-CF3Ph
f: Ar ) 4-FPh
g: Ar ) 4-ClPh
h: Ar ) 4-BrPh
i: Ar ) 4-Me2NPh
through an unprecedented Mont-K10-catalyzed nonreductive
ketone transamination, whose general applicability is cur-
rently under investigation.
a Isolated yields.
Considering the biological activity of 4(5)-acylamino-
imidazoles16 and the renewed interest in the synthesis of 4(5)-
aminoimidazoles,17 the reported rearrangement represents a
valid approach toward target imidazoles. The precursor
accessibility, the easy workup, and the good product yields,
encourage further use of this synthetic methodology.
Deprotonation under basic conditions generates the X )
Y-Z- anionic side chain where Z- is the nucleophilic site
attacking the N(2). In substrates 4a-i, such deprotonated
side chain can be achieved considering the potential acidic
character of methine C-H directly linked to C(3) of the
oxadiazole ring. In fact, thermal rearrangement reactions of
4a-i under basic conditions (t-BuOK) in refluxing DMF
yielded imidazoles 5a-i in good to high yields (Table 2).
On the other hand, attempts to perform this rearrangement
in the absence of a base by refluxing compounds 4 in most
common organic solvents (toluene, benzene, DMF, aceto-
nitrile) or by heating under solvent-free conditions, led to
decomposition of starting material. Moreover, the use of
protic solvents (MeOH, EtOH) led to hydrolysis of the imines
4a-i into amine 7 and the corresponding aldehyde 8a-i.
These findings confirmed the requirement of a base for the
reaction to occur. From a mechanistic point of view, the
driving force of the reaction could be ascribed to the higher
aromatic stabilization of the imidazole ring with respect to
the 1,2,4-oxadiazole, according to Bird’s index.15 According
to the general scheme of the BK rearrangement, the involve-
ment of the base in the formation of imidazoles 5 is explained
through the initial formation of allyl anions 9, which
undergoes an internal nucleophilic substitution at the pivotal
Acknowledgment. Financial support through the Univer-
sity of Palermo is gratefully acknowledged.
Supporting Information Available: Synthetic details,
characterization data, and 1H and 13C NMR spectra of
compounds 4, 5, and 7. This material is available free of
OL1013087
(16) See for example: (a) Palkowitz, A. D.; Steinberg, M. I.; Thrasher,
K. J.; Reel, J. K.; Hauser, K. L.; Zimmerman, K. M.; Wiest, S. A.; Whitesitt,
C. A.; Simon, R. L.; Heifer, W.; Lifer, S. L.; Boyd, D. B.; Barnett, C. J.;
Wilson, T. M.; Deeter, J. B.; Takeuchi, K.; Riley, R. E.; Miller, W. D.;
Marshall, W. S. J. Med. Chem. 1994, 37, 4508–4521. (b) Zhu, Y.; Gross,
T. D.; Gao, Y.; Connors, P. J., Jr.; Guo, Z.; Chen, C. PCT Int. Appl. WO
01/29044, 2001. (c) Ahlijanian, M. K.; Cooper, C. B.; Helal, C. J.; Lau,
L.-F.; Menniti, F.; Sanner, M. A.; Seymour, P. A.; Villalobos, A. WO Patent
02/10141A1, 2002. (d) Lugar, C. W.; Clay, M. P.; Lindstrom, T. D.;
Woodson, A. L.; Smiley, D.; Heiman, M. L.; Dodge, J. A. Bioorg. Med.
Chem. Lett. 2004, 14, 5873–5876. (e) Reigan, P.; Edwards, P. N.; Gbaj,
A.; Cole, C.; Barry, S. T.; Page, K. M.; Ashton, S. E.; Luke, R. W. A.;
Douglas, K. T.; Stratford, I. J.; Jaffar, M.; Bryce, R. A.; Freeman, S. J. Med.
Chem. 2005, 48, 392–402. (f) Bauser, M.; Buchmueller, A.; Von Degenfeld,
G.; Dittrich-Wengenroth, E.; Gerdes, C.; Gnoth, M. J.; Gottschling, D.;
Heitmeier, S.; Hendrix, M.; Koebberling, J. PCT Int. Appl. WO 2008043533,
2008. (g) Helal, C. J.; Kang, Z.; Lucas, J. C.; Gant, T.; Ahlijanian, M. K.;
Schachter, J. B.; Richter, K. E. G.; Cook, J. M.; Menniti, F. S.; Kelly, K.;
Mente, S.; Pandit, J.; Hosea, N. Bioorg. Med. Chem. Lett. 2009, 19, 5703–
5707.
(15) (a) Bird, C. W. Tetrahedron 1985, 41, 1409–1414. (b) Katritzky,
A. R.; Barczynski, P.; Musumarra, G.; Pisano, D.; Szafran, M. J. Am. Chem.
Soc. 1989, 111, 7–15. (c) Bird, C. W. Tetrahedron 1992, 48, 335–340. (d)
Katritzky, A. R.; Jug, K.; Oniciu, D. C. Chem. ReV. 2001, 101, 1421–1449.
(e) Balaban, A. T.; Oniciu, D. C.; Katritzky, A. R. Chem. ReV. 2004, 104,
2777–2812.
(17) Soh, C. H.; Chui, W. K.; Lam, Y. J. Comb. Chem. 2006, 8, 464–
468.
Org. Lett., Vol. 12, No. 15, 2010
3493